Insights from 2023 ASH Annual Meeting
Video Player is loading.
10 seconds
Playback speed
TN-CLL/SLL: Combination Treatment With Sonrotoclax (BGB-11417), a 2nd-Gen BCL2i, and Zanubrutinib
By
Insights from 2023 ASH Annual Meeting
FEATURING
Mary Ann Anderson
By
Insights from 2023 ASH Annual Meeting
FEATURING
Mary Ann Anderson
Comments 0
Login to view comments.
Click here to Login
